Cargando…

Prophylactic and therapeutic treatment with a synthetic analogue of a parasitic worm product prevents experimental arthritis and inhibits IL-1β production via NRF2-mediated counter-regulation of the inflammasome

Rheumatoid arthritis (RA) remains a debilitating autoimmune condition as many patients are refractory to existing conventional and biologic therapies, and hence successful development of novel treatments remains a critical requirement. Towards this, we now describe a synthetic drug-like small molecu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rzepecka, Justyna, Pineda, Miguel A., Al-Riyami, Lamyaa, Rodgers, David T., Huggan, Judith K., Lumb, Felicity E., Khalaf, Abedawn I., Meakin, Paul J., Corbet, Marlene, Ashford, Michael L., Suckling, Colin J., Harnett, Margaret M., Harnett, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academic Press 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459730/ https://www.ncbi.nlm.nih.gov/pubmed/25975491 http://dx.doi.org/10.1016/j.jaut.2015.04.005

Ejemplares similares

Designing Anti-inflammatory Drugs from Parasitic Worms: A Synthetic Small Molecule Analogue of the Acanthocheilonema viteae Product ES-62 Prevents Development of Collagen-Induced Arthritis
por: Al-Riyami, Lamyaa, et al.
Publicado: (2013)

The Parasitic Worm Product ES-62 Targets Myeloid Differentiation Factor 88–Dependent Effector Mechanisms to Suppress Antinuclear Antibody Production and Proteinuria in MRL/lpr Mice
por: Rodgers, David T, et al.
Publicado: (2015)

Small molecule analogues of the immunomodulatory parasitic helminth product ES-62 have anti-allergy properties
por: Rzepecka, Justyna, et al.
Publicado: (2014)

Dendritic cells provide a therapeutic target for synthetic small molecule analogues of the parasitic worm product, ES-62
por: Lumb, Felicity E., et al.
Publicado: (2017)

Protective effect of small molecule analogues of the Acanthocheilonema viteae secreted product ES-62 on oxazolone-induced ear inflammation
por: Al-Riyami, Lamyaa, et al.
Publicado: (2015)

Suppression of inflammatory arthritis by the parasitic worm product ES-62 is associated with epigenetic changes in synovial fibroblasts
por: Corbet, Marlene, et al.
Publicado: (2021)

IL-33/ST2 signalling and crosstalk with FcεRI and TLR4 is targeted by the parasitic worm product, ES-62
por: Ball, Dimity H., et al.
Publicado: (2018)

The role of individual protein kinase C isoforms in mouse mast cell function and their targeting by the immunomodulatory parasitic worm product, ES-62
por: Bell, Kara S., et al.
Publicado: (2015)

Protection against collagen-induced arthritis in mice afforded by the parasitic worm product, ES-62, is associated with restoration of the levels of interleukin-10-producing B cells and reduced plasma cell infiltration of the joints
por: Rodgers, David T, et al.
Publicado: (2014)

Failure of the Anti-Inflammatory Parasitic Worm Product ES-62 to Provide Protection in Mouse Models of Type I Diabetes, Multiple Sclerosis, and Inflammatory Bowel Disease
por: Doonan, James, et al.
Publicado: (2018)

Development of Acanthocheilonema viteae in Meriones shawi: Absence of microfilariae and production of active ES‐62
por: Lumb, Felicity E., et al.
Publicado: (2020)

Protection Against Arthritis by the Parasitic Worm Product ES-62, and Its Drug-Like Small Molecule Analogues, Is Associated With Inhibition of Osteoclastogenesis
por: Doonan, James, et al.
Publicado: (2018)

Mast Cell Subsets and Their Functional Modulation by the Acanthocheilonema viteae Product ES-62
por: Ball, Dimity H., et al.
Publicado: (2013)

The parasitic worm product ES-62 protects the osteoimmunology axis in a mouse model of obesity-accelerated ageing
por: Harnett, Margaret M., et al.
Publicado: (2022)

The parasitic worm-derived immunomodulator, ES-62 and its drug-like small molecule analogues exhibit therapeutic potential in a model of chronic asthma
por: Coltherd, J. C., et al.
Publicado: (2016)

The helminth product, ES-62, protects against airway inflammation by resetting the Th cell phenotype
por: Rzepecka, Justyna, et al.
Publicado: (2013)

The parasitic worm product ES-62 normalises the gut microbiota bone marrow axis in inflammatory arthritis
por: Doonan, James, et al.
Publicado: (2019)

ES‐62 Protects Against Collagen‐Induced Arthritis by Resetting Interleukin‐22 Toward Resolution of Inflammation in the Joints
por: Pineda, Miguel A., et al.
Publicado: (2014)

Drug-like analogues of the parasitic worm-derived immunomodulator ES-62 are therapeutic in the MRL/Lpr model of systemic lupus erythematosus
por: Rodgers, D T, et al.
Publicado: (2015)

Site-specific glycoproteomic characterization of ES-62: The major secreted product of the parasitic worm Acanthocheilonema viteae
por: North, Simon J, et al.
Publicado: (2019)

Testing small molecule analogues of the Acanthocheilonema viteae immunomodulator ES‐62 against clinically relevant allergens
por: Janicova, L., et al.
Publicado: (2016)

Small Molecule Analogues of the parasitic worm product ES-62 interact with the TIR domain of MyD88 to inhibit pro-inflammatory signalling
por: Suckling, Colin J., et al.
Publicado: (2018)

The helminth product, ES-62 modulates dendritic cell responses by inducing the selective autophagolysosomal degradation of TLR-transducers, as exemplified by PKCδ
por: Eason, Russell J., et al.
Publicado: (2016)

The parasitic worm product ES-62 promotes health- and life-span in a high calorie diet-accelerated mouse model of ageing
por: Crowe, Jenny, et al.
Publicado: (2020)

The Carbohydrate-linked Phosphorylcholine of the Parasitic Nematode Product ES-62 Modulates Complement Activation
por: Ahmed, Umul Kulthum, et al.
Publicado: (2016)

Lessons from helminth infections: ES-62 highlights new interventional approaches in rheumatoid arthritis
por: Pineda, M A, et al.
Publicado: (2014)

2,2,2-Trifluoro-N-(isoquinolin-5-ylmethyl)acetamide
por: Kennedy, Alan R., et al.
Publicado: (2009)

Prevalence and Characteristics of Australians Complementary Medicine Product Use, and Concurrent Use with Prescription and Over-the-Counter Medications—A Cross Sectional Study
por: Harnett, Joanna, et al.
Publicado: (2023)

Structure-Based Design and Synthesis of Antiparasitic Pyrrolopyrimidines Targeting Pteridine Reductase 1
por: Khalaf, Abedawn I., et al.
Publicado: (2014)

Crystal structure of N,N-dimethyl-2-[(4-methylbenzyl)sulfonyl]ethanamine
por: Kennedy, Alan R., et al.
Publicado: (2015)

Four pyrrole derivatives used as building blocks in the synthesis of minor-groove binders
por: Kennedy, Alan R., et al.
Publicado: (2017)

On the Production of Worms in the Human Body
por: Scouler, John
Publicado: (1830)

An analysis of the impact of Newcastle disease vaccination and husbandry practice on smallholder chicken productivity in Uganda
por: Bessell, Paul R, et al.
Publicado: (2020)

A high level estimation of the net economic benefits to small-scale livestock producers arising from animal health product distribution initiatives
por: Bessell, Paul R., et al.
Publicado: (2023)

Dr. Scouler on the Production of Worms in the Human Body
Publicado: (1830)

An evaluation of Minor Groove Binders as anti-Trypanosoma brucei brucei therapeutics
por: Scott, Fraser J., et al.
Publicado: (2016)

Interactions between natural products and cancer treatments: underlying mechanisms and clinical importance
por: Chan, Wai-Jo Jocelin, et al.
Publicado: (2023)

Use of complementary medicine products: a nationally representative cross-sectional survey of 2019 Australian adults
por: Harnett, Joanna E, et al.
Publicado: (2019)

Learning Articulate Storyline
por: Harnett, Stephanie
Publicado: (2013)

On the Application of Artificial Teeth upon the Atmospheric Pressure, or Suction Principle
por: Harnett, William
Publicado: (1845)

Cannot write session to /tmp/vufind_sessions/sess_corll4qa1v5gjb5q9q09cs77q8